Search Results - "COLINET, B"

Valproate―doxorubicin: promising therapy for progressing mesothelioma. A phase II study by SCHERPEREEL, A, BERGHMANS, T, WILLEMS, L, SCULIER, J. P, LAFITTE, J. J, COLINET, B, RICHEZ, M, BONDUELLE, Y, MEERT, A. P, DHALLUIN, X, LECLERCQ, N, PAESMANS, M

“…No treatment is recommended for patients with malignant mesothelioma (MM) failing after first-line cisplatin-based chemotherapy. In vitro data suggested that…”
Get full text

A case of Sweet syndrome in a patient receiving erlotinib for lung adenocarcinoma by Ahangari, D, Ngendahayo, P, Colinet, B, Roquet-Gravy, P-P

“…Sweet syndrome is a neutrophilic dermatosis and is often idiopathic, although its onset may be drug-induced or paraneoplastic. The purpose of this case report…”
Get full text

Quality of life and comorbidity score as prognostic determinants in non-small-cell lung cancer patients by Jacot, W., Colinet, B., Bertrand, D., Lacombe, S., Bozonnat, M.-C., Daurès, J.-P., Pujol, J.-L.

“…Both quality of life (QoL) and comorbidity influence therapy and prognosis of non-small-cell lung cancer (NSCLC). We previously developed a lung cancer…”
Get full text

A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index by COLINET, B, JACOT, W, BERTRAND, D, LACOMBE, S, BOZONNAT, M.-C, DAURES, J.-P, PUJOL, J.-L

“…Treatment of non-small-cell lung cancer (NSCLC) might take into account comorbidities as an important variable. The aim of this study was to generate a new…”
Get full text

Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD by Pilette, C, Colinet, B, Kiss, R, Andre, S, Kaltner, H, Gabius, H-J, Delos, M, Vaerman, J-P, Decramer, M, Sibille, Y

“…Galectins-1 and -3 regulate epithelial proliferation/apoptosis and neutrophil activation, and are implicated in lung cancer and asthma. The role of galectins…”
Get full text

Preoperative frailty assessment: a review by Bissot, M, Henin, P Y, Aunac, S, Colinet, B, Barvais, L, Simonet, O, De Kock, M

“…Elderly surgical population is growing faster than the rate of population ageing. The risk of postoperative complication is higher in this population, the type…”
Get full text

Pulmonary nodules and arachnophobia by Colinet, B, Dargent, J-L, Fremault, A

“…Pulmonary nodules are a common reason for consultation and their investigation must always exclude a possible neoplastic cause. This means that, in addition to…”
Get more information

Obliterative bronchiolitis with organising pneumonia following FOLFOX 4 chemotherapy by Dahlqvist, C, Fremault, A, Carrasco, J, Colinet, B

“…FOLFOX 4 chemotherapy (5-fluorouracil, leucovorin and oxaliplatin) is the standard adjuvant treatment for stage III colon cancer. The principal secondary…”
Get more information

The relationship between the fracture toughness and grain boundary characteristics in hot-dip galvanized zinc coatings by VINCENT, G, BONASSO, N, LECOMTE, J. S, COLINET, B, GAY, B, ESLING, C

“…This publication presents an experimental study on the relation between the grain boundary (GB) characteristics and the intergranular cracking resistance in a…”
Get full text

Echocardiography for management of low cardiac output state after axillary block in a dehydrated patient with aortic stenosis : case report by DELVAUX, B, COLINET, B

“…We report an episode of transient low cardiac output in a dehydrated elderly woman having an undetected clinically significant aortic stenosis, after an…”
Get full text

1363P Real-world treatment patterns of patients with locally advanced/metastatic EGFRm NSCLC in Belgium (REVEAL) by Cuppens, K., Lodewyckx, L., Demedts, I., Decoster, L., Colinet, B., Deschepper, K., Janssens, A., Galdermans, D., Pieters, T.

Get full text

2000P Real-world EGFR testing in patients with advanced EGFRm NSCLC in Belgium (REVEAL) by Cuppens, K., Lodewyckx, L., Demedts, I., Decoster, L., Colinet, B., Deschepper, K., Janssens, A., Pauwels, P., Galdermans, D., Pieters, T.

Get full text

1176P Open-label, dose escalation, phase I/II study to assess safety, tolerability, immunogenicity and preliminary clinical activity of the therapeutic cancer vaccine PDClung01 with or without anti-programmed death-1 (PD-1) treatment in patients with non-small cell lung cancer (NSCLC) by Vansteenkiste, J.F., Demedts, I., Pons-Tostivint, E., Biesma, B., Borm, F., Colinet, B., Cuppens, K., Derijcke, S., Greillier, L., Jürgens, J., Moro-Sibilot, D., Pérol, M., Sebastian, M., Skrzypski, M., Theelen, W., Van De Kerkhove, C., Collodoro, M., Plumas, J., Debruyne, C., Sibille, A.

Get full text

Lung Adenocarcinoma Mimicking a Bilateral Cavitary Pneumonia by Mahiat, Cédric, Colinet, Benoît, Poncelet, Pierre-Antoine

“…Teaching Point: Failure to recognize unusual radiological presentations of some lung adenocarcinomas can lead to misdiagnosis and/or delay appropriate…”
Get full text

Syndrome de Sweet chez une patiente traitée par erlotinib pour un adénocarcinome bronchique by Ahangari, D., Ngendahayo, P., Colinet, B., Roquet-Gravy, P.-P.

“…Le syndrome de Sweet est une dermatose neutrophilique souvent idiopathique, mais qui peut également se manifester après la prise de certains médicaments ou…”
Get full text

A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer by Berghmans, Thierry, Scherpereel, Arnaud, Meert, Anne-Pascale, Giner, Vicente, Lecomte, Jacques, Lafitte, Jean-Jacques, Leclercq, Nathalie, Paesmans, Marianne, Sculier, Jean-Paul

“…In a literature meta-analysis, we showed survival benefits for regimens including cisplatin [hazard ratio (HR) 0.61; 95% confidence interval (CI), 0.57-0.66]…”
Get full text

Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies††These studies have previously been presented in part at the ASCO 2013 Annual Meeting, the ESMO-ECCO 2013 Annual Meeting and the IASLC 2013 World Conference on Lung Cancer by Moran, T., Wei, J., Qian, X., Domine, M., Zou, Z., Wang, L., Provencio, M., Yu, L., Song, Y., Vergnenegre, A., Lu, H., Lopez-Vivanco, G., Majem, M., Chen, X., Karachaliou, N., Sala, M.A., Wu, Q., Isla, D., Baize, N., Zhang, F., Garde, J., Germonpre, P., Drozdowskyj, A., Sanchez, J.J., Liu, B., Rosell, R., De Grève, J., Germonpré, P., Chen, H., Chen, X., Gao, Y., Hu, W., Kong, W., Li, L., Li, X., Lu, H., Qian, X., Ren, W., Song, Y., Wei, J., Xu, X., Yang, J., Yang, M., Yue, X., Zhang, J., Zou, Z., Bombaron, P., Dansin, E., Fraboulet, G., Hominal, S., Kahlout, S., Lecaer, H., Lena, H., Monnet, I., Oliviero, G., Schoot, R., Vergnènegre, A., Berchem, G., Al Husaini, H., Aparisi, F., Arriola, E., Bernabé, R., Bosch-Barrera, J., Bover, I., Calvo de Juan, V., Cobo, M., De las Peñas, R., García-Girón, C., García-Gómez, R., Garcia-Sevila, R., Garde, J., Gasco, A., González-Larriba, J.L., Hernando-Polo, S., Jantus, E., Isla, D., Jiménez, B., Lianes, P., López-Martín, A., Macias, J.A., Marti-Ciriquian, J.L., Morán, T., Moreno, M.A., Pallares, C., Porta, R., Reguart, N., Rosell, R., Rosillo, F., Sala, M.A., Sanchez, J.M., Trigo, J.M., Viteri, S., Mate, J.L., Perez-Cano, M., Ramirez, J.L., Sanchez-Rodriguez, B., Ocaña, J., Pereira, E., Shao, J., Sun, X.

“…In a Spanish Lung Cancer Group (SLCG) phase II trial, the combination of BRCA1 and receptor-associated protein 80 (RAP80) expression was significantly…”
Get full text

First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (pts) (NCT00339586)—FIELT study group by De Greve, J., Van Meerbeeck, J. P., Vansteenkiste, J. F., Teugels, E., Geers, C., Meert, A., Vuylsteke, P., Focan, C. N. J., Canon, J., Humblet, Y., Berchem, G. J., Colinet, B., Galdermans, D., Bosquée, L., Dooms, C. A., Decoster, L., Vermeij, J., Dewaele, A., Schallier, D. C. C.

“…Abstract only…”
Get full text

Phase II study of induction chemotherapy with cisplatin (Cis) and gemcitabine (Gem) followed by concomitant Cis-Gem and thoracic radiation (RTX) for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Driesen, P., Verbeke, L., Lonchay, C., Lambrechts, M., Mentens, Y., Carestia, L., Rosier, J., Colinet, B., Chouaki, N., Kraaij, K. J.

“…Abstract only 7550 Background: In the CALGB Study Cis with Gem followed by concomitant chemoradiation for inoperable LA-NSCLC was effective, however with…”
Get full text

The relationship between the fracture toughness and grain boundary characteristics in hot-dip galvanized zinc coatings by Vincent, G, Bonasso, N, Lecomte, J.S., Colinet, B, Gay, B, Esling, C

“…This publication presents an experimental study on the relation between the grain boundary (GB) characteristics and the intergranular cracking resistance in a…”
Get full text